V02-12: Does Size Matter? Performance of Prostatic Urethral Lift in Men with Prostate Volumes 80 grams
Benign prostatic hyperplasia (BPH) with associated lower urinary tract symptoms (LUTS) has a significant impact on quality of life. It is estimated by 2020, 8.5 million men will have LUTS secondary to BPH. Prostatic urethral lift (PUL) is a minimally invasive procedure with strong 5-year durability, minimal side effect profile, and no associated erectile or ejaculatory dysfunction. We aim to demonstrate our PUL technique and to evaluate the performance of the prostatic urethral lift in men with prostate volumes 80 grams.
We completed a retrospective chart review of men with prostate volumes 80 grams who underwent PUL in the office from January 2016 to August 2017. Preoperative flexible cystoscopy and transrectal ultrasound were performed. PUL, also known as Urolift (NeoTract, Pleasanton, CA, USA), was performed in the office under sedation by a single surgeon. A foley catheter was placed after the procedure and removed the next day in clinic. International prostatic symptom score (IPSS), quality of life (QOL), and post void residual (PVR) were recorded preoperatively and at 6 months. Mean values were compared using a t-test with p
26 men underwent an office PUL with prostate volumes 80 grams (n=13). Patient demographics are summarized in Table 1. Mean improvement in PVR at 6 months was 175cc (p0.05) in the 80 gram groups respectively. Mean IPSS decreased by 17.56 (p 80 gram groups respectively. QOL improved by 2.45 (p
Our series demonstrated statistically significant improvement in IPSS and QOL at 6 month follow up in both cohorts. Further follow up is required to assess the durability of the prostatic urethral lift in prostates 80 grams.